Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Thomusch

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Transplantation Proceedings|March 1, 2020
Evidence of Interleukin-2-Receptor-Antibody Induction in Low-Risk Living Donor Kidney Transplantation: A Single-Center Pilot StudyBernd Martin Jänigen, Susanne Gehrmann, Torben Glatz, et al.
Trials|February 10, 2011
Hand-suture versus stapling for closure of loop ileostomy: HASTA-Trial: a study rationale and design for a randomized controlled trialThorsten Löffler, Christoph M Seiler, Inga Rossion, et al.
Lancet (London, England)|November 23, 2016
Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trialOliver Thomusch, Michael Wiesener, Mirian Opgenoorth, et al.
BMC Immunology|April 29, 2019
A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantationNicole Wittenbrink, Sabrina Herrmann, Arturo Blazquez-Navarro, et al.
Ebiomedicine|August 4, 2018
BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre StudyArturo Blazquez-Navarro, Chantip Dang-Heine, Nicole Wittenbrink, et al.
Surgery|January 20, 2005
Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgeryHenning Dralle, Carsten Sekulla, Johannes Haerting, et al.
Kidney International|March 15, 2013
The genetic predisposition of natural killer cell to BK virus-associated nephropathy in renal transplant patientsHanna Trydzenskaya, Karsten Juerchott, Nils Lachmann, et al.
Journal of Nephrology|December 2, 2022
Lack of predictive capacity of pre-transplant anti-BK virus antibodies for post-transplant reactivationArturo Blazquez-Navarro, Toralf Roch, Patrizia Wehler, et al.
Scientific Reports|November 12, 2020
The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantationSharon Bajda, Arturo Blazquez-Navarro, Björn Samans, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 30, 2023
Excellent efficacy and beneficial safety during observational 5-year follow-up of rapid steroid withdrawal after renal transplantation (Harmony FU study)Julian Stumpf, Oliver Thomusch, Mirian Opgenoorth, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Transplantation Proceedings|March 1, 2020
Evidence of Interleukin-2-Receptor-Antibody Induction in Low-Risk Living Donor Kidney Transplantation: A Single-Center Pilot StudyBernd Martin Jänigen, Susanne Gehrmann, Torben Glatz, et al.
Trials|February 10, 2011
Hand-suture versus stapling for closure of loop ileostomy: HASTA-Trial: a study rationale and design for a randomized controlled trialThorsten Löffler, Christoph M Seiler, Inga Rossion, et al.
Lancet (London, England)|November 23, 2016
Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trialOliver Thomusch, Michael Wiesener, Mirian Opgenoorth, et al.
BMC Immunology|April 29, 2019
A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantationNicole Wittenbrink, Sabrina Herrmann, Arturo Blazquez-Navarro, et al.
Ebiomedicine|August 4, 2018
BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre StudyArturo Blazquez-Navarro, Chantip Dang-Heine, Nicole Wittenbrink, et al.
Surgery|January 20, 2005
Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgeryHenning Dralle, Carsten Sekulla, Johannes Haerting, et al.
Kidney International|March 15, 2013
The genetic predisposition of natural killer cell to BK virus-associated nephropathy in renal transplant patientsHanna Trydzenskaya, Karsten Juerchott, Nils Lachmann, et al.
Journal of Nephrology|December 2, 2022
Lack of predictive capacity of pre-transplant anti-BK virus antibodies for post-transplant reactivationArturo Blazquez-Navarro, Toralf Roch, Patrizia Wehler, et al.
Scientific Reports|November 12, 2020
The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantationSharon Bajda, Arturo Blazquez-Navarro, Björn Samans, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 30, 2023
Excellent efficacy and beneficial safety during observational 5-year follow-up of rapid steroid withdrawal after renal transplantation (Harmony FU study)Julian Stumpf, Oliver Thomusch, Mirian Opgenoorth, et al.
Pageof 5